Location: New York, NY
CIK: 0001609251 · Show all filings
Period: Q4 2016 (← Previous) (Next →)
Filing Date: Feb 13, 2017
Total Value: $279M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 270,909 | $38.86M | 13.9% | $136.10 | -6.2% | COM | 91307C102 |
| ENTA | ENANTA PHARMACEUTICALS INC | 1,055,719 | $35.37M | 12.7% | $35.89 | -20.1% | COM | 29251M106 |
| GILD | GILEAD SCIENCES INC | 420,000 | $30.08M | 10.8% | $53.19 | 0.0% | COM | 375558103 |
| — | SUCAMPO PHARMACEUTICALS-CL A | 1,863,755 | $25.25M | 9.1% | $12.34 | — | COM | 864909106 |
| OM2 | ORTHOFIX INTERNATIONAL NV | 645,530 | $23.36M | 8.4% | $32.01 | — | COM | N6748L102 |
| — | HALYARD HEALTH INC | 564,792 | $20.89M | 7.5% | $40.74 | — | COM | 40650V100 |
| AMGN | AMGEN INC | 127,157 | $18.59M | 6.7% | $114.37 | 0.0% | COM | 031162100 |
| — | INDIVIOR PLC | 4,650,416 | $16.97M | 6.1% | $3.34 | — | COM | G4766E108 |
| MRK | MERCK & CO. INC. | 252,874 | $14.89M | 5.3% | $39.26 | +12.3% | COM | 58933Y105 |
| CNMD | CONMED CORP | 328,677 | $14.52M | 5.2% | $37.99 | +1.9% | COM | 207410101 |
| — | INVACARE CORP | 1,102,586 | $14.39M | 5.2% | $14.01 | — | COM | 461203101 |
| — | RTI SURGICAL INC | 4,216,948 | $13.71M | 4.9% | $4.41 | — | COM | 74975N105 |
| — | DERMA SCIENCES INC | 891,026 | $4.633M | 1.7% | $4.57 | — | COM | 249827502 |
| — | AVIRAGEN THERAPEUTICS INC | 2,737,602 | $3.367M | 1.2% | $1.23 | — | COM | 053761102 |
| — | DIGIRAD CORP | 486,400 | $2.432M | 0.9% | $4.41 | — | COM | 253827109 |
| — | JUNIPER PHARMACEUTICALS INC | 290,853 | $1.629M | 0.6% | $9.19 | — | COM | 48203L107 |